Skip to content

GARDEN STAGE LIMITED: 20-F filed 2026-07-31

What GARDEN STAGE LIMITED reported in its annual report (foreign private issuer) filed 2026-07-31 (fiscal FY 2026): 39 published measures, 94 facts as tagged in accession 0001213900-26-083626.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2026-07-31
Fiscal period
fiscal FY 2026
Accession
0001213900-26-083626 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GARDEN STAGE LIMITED filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-03-3141,925,100USD
At 2025-03-3115,899,405USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-03-3117,703,121USD
At 2025-03-319,197,002USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-03-3124,221,979USD
At 2025-03-316,702,403USD
At 2024-03-319,285,488USD
At 2023-03-311,947,006USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-13,838,227USD365
2024-04-01 to 2025-03-31-4,317,642USD365
2023-04-01 to 2024-03-31-4,589,478USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-4,234,334USD365
2024-04-01 to 2025-03-31-1,148,574USD365
2023-04-01 to 2024-03-31-7,090,770USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-04-01 to 2026-03-317,278,837USD365
2024-04-01 to 2025-03-315,466,243USD365
2023-04-01 to 2024-03-311,408,469USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-04-01 to 2026-03-3120,398,998USD365
2024-04-01 to 2025-03-31263,485USD365
2023-04-01 to 2024-03-319,693,950USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-6,310,193USD365
2024-04-01 to 2025-03-31-218,235USD365
2023-04-01 to 2024-03-31-1,448USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-03-31-22,824,842USD
At 2025-03-31-8,986,615USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2026-03-319,999,506shares365
2024-04-01 to 2025-03-319,281,875shares365
2023-04-01 to 2024-03-319,271,806shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2026-03-319,999,506shares365
2024-04-01 to 2025-03-319,281,875shares365
2023-04-01 to 2024-03-319,271,806shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2026-03-311.38USD/shares365
2024-04-01 to 2025-03-310.47USD/shares365
2023-04-01 to 2024-03-310.49USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2026-03-311.38USD/shares365
2024-04-01 to 2025-03-310.47USD/shares365
2023-04-01 to 2024-03-310.49USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-22,785USD365
2024-04-01 to 2025-03-3143,234USD365
2023-04-01 to 2024-03-3113,359USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2026-03-31160,457USD
At 2025-03-31164,847USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-04-01 to 2026-03-314,529,716USD365
2024-04-01 to 2025-03-311,684,642USD365
2023-04-01 to 2024-03-311,871,499USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-03-3130,503,440USD
At 2025-03-3113,772,983USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-03-3117,703,121USD
At 2025-03-319,115,718USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2026-03-3111,037,728USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2026-03-3121,139,849USD365
2024-04-01 to 2025-03-319,740,651USD365
2023-04-01 to 2024-03-315,984,588USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2026-03-31947,571USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-319,281,875shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-03-3117,523,381USD
At 2025-03-317,885,624USD
At 2024-03-318,938,202USD
At 2023-03-316,317,200USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-03-31-310,348USD
At 2025-03-31-30,909USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2026-03-3188,173USD
At 2025-03-31185,684USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2026-03-3180,705USD
At 2025-03-31199,102USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2026-03-31174,475USD
At 2025-03-3167,453USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2026-03-3111,101,539USD
At 2025-03-3164,268USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2026-03-3125,931USD
At 2025-03-3168,290USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-13,861,012USD365
2024-04-01 to 2025-03-31-4,274,408USD365
2023-04-01 to 2024-03-31-4,576,119USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-14,117,666USD365
2024-04-01 to 2025-03-31-4,267,727USD365
2023-04-01 to 2024-03-31-4,671,328USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-04-01 to 2026-03-31107,940USD365
2024-04-01 to 2025-03-3158,762USD365
2023-04-01 to 2024-03-319,421USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2026-03-311,015,553USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-874USD365
2024-04-01 to 2025-03-3164,427USD365
2023-04-01 to 2024-03-3115,856USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2025-04-01 to 2026-03-31-21,911USD365
2024-04-01 to 2025-03-31-21,193USD365
2023-04-01 to 2024-03-31-2,497USD366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-04-01 to 2026-03-3166,949USD365
2024-04-01 to 2025-03-3116,565USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-04-01 to 2026-03-3120,641,722USD365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-04-01 to 2026-03-31123,016USD365
2024-04-01 to 2025-03-31102,636USD365
2023-04-01 to 2024-03-3170,534USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-04-01 to 2026-03-31951,434USD365

Inspect the source

Entity
GARDEN STAGE LIMITED / CIK 0001954269
Captured
2026-09-21T17:36:16.979Z
SEC response SHA-256
18b311a1f9c283d365ad80b3b99d8926ab8c844ad595681b34b7789be8fcadd9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001954269.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))